Literature DB >> 35312310

Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes.

Yi-Hua Jan1, Diane E Heck2, Yunqi An3, Debra L Laskin3, Jeffrey D Laskin1.   

Abstract

Cytotoxic blistering agents such as sulfur mustard and nitrogen mustard (HN2) were synthesized for chemical warfare. Toxicity is due to reactive chloroethyl side chains that modify and damage cellular macromolecules including DNA and proteins. In response to DNA damage, cells initiate a DNA damage response directed at the recruitment and activation of repair-related proteins. A central mediator of the DNA damage response is p53, a protein that plays a critical role in regulating DNA repair. We found that HN2 causes cytosolic and nuclear accumulation of p53 in HaCaT keratinocytes; HN2 also induced post-translational modifications on p53 including S15 phosphorylation and K382 acetylation, which enhance p53 stability, promote DNA repair, and mediate cellular metabolic responses to stress. HN2 also cross-linked p53, forming dimers and high-molecular-weight protein complexes in the cells. Cross-linked multimers were also modified by K48-linked ubiquitination indicating that they are targets for proteasome degradation. HN2-induced modifications transiently suppressed the transcriptional activity of p53. Using recombinant human p53, HN2 alkylation was found to be concentration- and redox status-dependent. Dithiothreitol-reduced protein was more efficiently cross-linked indicating that p53 cysteine residues play a key role in protein modification. LC-MS/MS analysis revealed that HN2 directly alkylated p53 at C124, C135, C141, C176, C182, C275, C277, H115, H178, K132, and K139, forming both monoadducts and cross-links. The formation of intermolecular complexes was a consequence of HN2 cross-linked cysteine residues between two molecules of p53. Together, these data demonstrate that p53 is a molecular target for mustard vesicants. Modification of p53 likely mediates cellular responses to HN2 including DNA repair and cell survival contributing to vesicant-induced cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35312310      PMCID: PMC9491701          DOI: 10.1021/acs.chemrestox.1c00420

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.973


  45 in total

1.  Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding.

Authors:  Joel L Kaar; Nicolas Basse; Andreas C Joerger; Elaine Stephens; Trevor J Rutherford; Alan R Fersht
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

2.  p53 mutations in human immortalized epithelial cell lines.

Authors:  T A Lehman; R Modali; P Boukamp; J Stanek; W P Bennett; J A Welsh; R A Metcalf; M R Stampfer; N Fusenig; E M Rogan
Journal:  Carcinogenesis       Date:  1993-05       Impact factor: 4.944

3.  The small molecule 2-phenylethynesulfonamide induces covalent modification of p53.

Authors:  Sarwat Jamil; Payman Hojabrpour; Vincent Duronio
Journal:  Biochem Biophys Res Commun       Date:  2016-11-07       Impact factor: 3.575

4.  Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress.

Authors:  Chinavenmeni S Velu; Suryakant K Niture; Catalin E Doneanu; Nagarajan Pattabiraman; Kalkunte S Srivenugopal
Journal:  Biochemistry       Date:  2007-06-08       Impact factor: 3.162

5.  Activation of DNA damage repair pathways in response to nitrogen mustard-induced DNA damage and toxicity in skin keratinocytes.

Authors:  Swetha Inturi; Neera Tewari-Singh; Chapla Agarwal; Carl W White; Rajesh Agarwal
Journal:  Mutat Res       Date:  2014-04-13       Impact factor: 2.433

Review 6.  Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.

Authors:  Rajesh K Singh; Sahil Kumar; D N Prasad; T R Bhardwaj
Journal:  Eur J Med Chem       Date:  2018-04-03       Impact factor: 6.514

Review 7.  The multiple mechanisms that regulate p53 activity and cell fate.

Authors:  Antonina Hafner; Martha L Bulyk; Ashwini Jambhekar; Galit Lahav
Journal:  Nat Rev Mol Cell Biol       Date:  2019-04       Impact factor: 94.444

8.  Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex.

Authors:  Henning Tidow; Roberto Melero; Efstratios Mylonas; Stefan M V Freund; J Guenter Grossmann; José María Carazo; Dmitri I Svergun; Mikel Valle; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

Review 9.  Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.

Authors:  Lindsey Carlsen; Wafik S El-Deiry
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

10.  2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells.

Authors:  Matthias R Bauer; Andreas C Joerger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.